really - how do they know. gaurantee - why even go out and try to sell. LOLNot sarcasm. They have really stepped up to take care of their people.
really - how do they know. gaurantee - why even go out and try to sell. LOL
Happy trails, nice working with you all
Where would we go - to another skin sub company?What BG and Leadership had done is nothing short of a master class in retaining the incredible talent at ORGO.
Mark my words it will be a HBR article in the near future.
Where would we go - to another skin sub company?
OK Carnack!there are companies with product on the covered list, but no enough for everyone.
also, implementation pushback until 10/1/23, and some big revisions to the lcd. I would guess an increase from 4 to at least 6 , and possibly a product like puraply being added back. No way novachor comes back tho
there are companies with product on the covered list, but no enough for everyone.
there are companies with product on the covered list, but no enough for everyone.
also, implementation pushback until 10/1/23, and some big revisions to the lcd. I would guess an increase from 4 to at least 6 , and possibly a product like puraply being added back. No way novachor comes back tho
there are companies with product on the covered list, but no enough for everyone.
also, implementation pushback until 10/1/23, and some big revisions to the lcd. I would guess an increase from 4 to at least 6 , and possibly a product like puraply being added back. No way novachor comes back tho
"We applaud the MACs and the Centers for Medicare & Medicaid Services (CMS) for carefully considering stakeholder concerns regarding the LCDs' potential negative impact and putting the needs of patients first in coming to this decision," said Gary S. Gillheeney, Sr., President, Chief Executive Officer, and Chair of the Board of Organogenesis.
Gillheeney added, "With this news, we wanted to take this opportunity to announce Danny Masterson will serve as the Company's official spokesperson. Danny's unique ability to force his way into getting what's best for Danny dovetails nicely with our 10+ year history of bending over the Medicare system."
Gillheeney concluded, "After leveraging our political currency, we are so excited to resume selling product that shall not be named off ASP price sheet for the financial benefit of our private office customers. The Company intends to up the rebate game while Mastersoning taxpayers."
“ non asp product revenue will be sustainable I GG am selling my stock at a all time high for new investors to ride the one trick pony “
